Skip to content

ZYBT - Zhengye Biotechnology Holding Ltd - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchZ

Zhengye Biotechnology Holding Limited Ordinary Shares

ZYBT · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

Z

ZYBTZhengye Biotechnology Holding Limited Ordinary Shares

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $13.08
52-wk low: $0.62
Prev close: $7.44
Mkt cap: $87.7M
P/S: 0.8x
P/B: 1.9x

Smart money

1 fund holds a position.

Real smart money

Funds holding this stock

1 holder

Combined position$93

JC
JPMorgan Chase
Q2 2026 13F
$93
position

Coverage gaps for ZYBT

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings

Earnings

Results versus expectations

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is not yet profitable.

Net margin: -60.0%
Market cap: $88M

Valuation

P/S0.75
P/B1.92

Quality

Operating margin-77.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: ZYBT
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: DRUG MANUFACTURERS - SPECIALTY & GENERIC
Market cap: $87.67M

Analysts

What do analysts expect?

No data yet

No analyst coverage yet for this stock.

We show it when enough analysts cover the stock.

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

Profit margin

-60.0%

Op margin

-77.0%

ROE

-25.2%

No earnings history on record for this stock yet.

The next reported quarter will appear here

Next report

What the street expects next

-25.2%

ROA-9.5%

Growth